Literature DB >> 17198305

Redefining early cervical neoplasia: recent progress.

Marisa R Nucci1, Christopher P Crum.   

Abstract

The classification of cervical precancers has evolved over the past 40 years as knowledge concerning the pathogenesis of these human papillomavirus-related lesions has expanded. This commentary reviews the current classification scheme in light of (1) the historical classification systems and (2) the ability of the target epithelium, that is the transformation zone to exhibit varied morphology depending on the cell type that is infected with human papillomavirus. The evolution in our understanding of preinvasive glandular neoplasia is also summarized, with particular attention to so-called superficial (or early) adenocarcinoma in situ. In addition, practical issues in the diagnosis and management of squamous epithelial lesions, particularly the recognition of nonconventional variants and the application of biomarkers, are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17198305     DOI: 10.1097/PAP.0b013e31802e0de7

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  7 in total

1.  MOLECULAR MARKERS OF EARLY CERVICAL NEOPLASIA.

Authors:  Alvaro P Pinto; Christopher P Crum; Michelle S Hirsch
Journal:  Diagn Histopathol (Oxf)       Date:  2010-10-01

Review 2.  [The 2019 FIGO classification for cervical carcinoma-what's new?]

Authors:  L-C Horn; C E Brambs; S Opitz; U A Ulrich; A K Höhn
Journal:  Pathologe       Date:  2019-11       Impact factor: 1.011

3.  [S3 guidelines on diagnostics and treatment of cervical cancer: Demands on pathology].

Authors:  L-C Horn; M W Beckmann; M Follmann; M C Koch; P Mallmann; S Marnitz; D Schmidt
Journal:  Pathologe       Date:  2015-11       Impact factor: 1.011

4.  p16 Immunohistochemistry Is Not Always Required For Accurate Diagnosis of Grade 2 Squamous Intraepithelial Lesions.

Authors:  Lulu Sun; Lingxin Zhang; Hannah R Krigman; Ian S Hagemann
Journal:  J Low Genit Tract Dis       Date:  2018-04       Impact factor: 1.925

5.  Cervical squamocolumnar junction-specific markers define distinct, clinically relevant subsets of low-grade squamous intraepithelial lesions.

Authors:  Michael Herfs; Carlos Parra-Herran; Brooke E Howitt; Anna R Laury; Marisa R Nucci; Sarah Feldman; Cynthia A Jimenez; Frank D McKeon; Wa Xian; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2013-09       Impact factor: 6.394

Review 6.  p16ink4 and cytokeratin 7 immunostaining in predicting HSIL outcome for low-grade squamous intraepithelial lesions: a case series, literature review and commentary.

Authors:  Eric C Huang; Mary M Tomic; Suchanan Hanamornroongruang; Emily E Meserve; Michael Herfs; Christopher P Crum
Journal:  Mod Pathol       Date:  2016-08-12       Impact factor: 7.842

7.  Human Papillomavirus Genotyping and p16(INK4a) Expression in Cervical Lesions: A Combined Test to Avoid Cervical Cancer Progression.

Authors:  Yassine Zouheir; Taoufiq Fechtali; Nadia Elgnaoui
Journal:  J Cancer Prev       Date:  2016-06-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.